Interferon-α immunocytokines targeting PD-L1 or CD20 demonstrated superior tumor control in lymphoma and colon cancer that was dependent on IFN-α receptor (IFNAR) expression in either the tumor cells or host immune cells [67,68]. Here, IFNAR1 is linked to neoplasm.